212 related articles for article (PubMed ID: 28558917)
1. Urinary F
Melton CD; Luo R; Wong BJ; Spasojevic I; Wagenknecht LE; D'Agostino RB; Il'yasova D
Ann Epidemiol; 2017 Jun; 27(6):391-396. PubMed ID: 28558917
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI.
Il'yasova D; Wang F; Spasojevic I; Base K; D'Agostino RB; Wagenknecht LE
Obesity (Silver Spring); 2012 Oct; 20(10):2147-50. PubMed ID: 22836686
[TBL] [Abstract][Full Text] [Related]
3. The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth.
Warolin J; Coenen KR; Kantor JL; Whitaker LE; Wang L; Acra SA; Roberts LJ; Buchowski MS
Pediatr Obes; 2014 Feb; 9(1):43-52. PubMed ID: 23296459
[TBL] [Abstract][Full Text] [Related]
4. Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort.
Il'yasova D; Wang F; Spasojevic I; Base K; D'Agostino RB; Wagenknecht LE
Obesity (Silver Spring); 2012 Sep; 20(9):1915-21. PubMed ID: 21959342
[TBL] [Abstract][Full Text] [Related]
5. Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes.
Il'yasova D; Morrow JD; Wagenknecht LE
Obes Res; 2005 Sep; 13(9):1638-44. PubMed ID: 16222068
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease risk factors and oxidative stress among premenopausal women.
Anderson C; Milne GL; Park YM; Sandler DP; Nichols HB
Free Radic Biol Med; 2018 Feb; 115():246-251. PubMed ID: 29229550
[TBL] [Abstract][Full Text] [Related]
7. Urinary F2-isoprostanes and metabolic markers of fat oxidation.
Il'yasova D; Wagenknecht LE; Spasojevic I; Watkins S; Bowden D; Wang F; D'Agostino RB
Oxid Med Cell Longev; 2015; 2015():729191. PubMed ID: 25802683
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in relation to diet and physical activity among premenopausal women.
Anderson C; Milne GL; Sandler DP; Nichols HB
Br J Nutr; 2016 Oct; 116(8):1416-1424. PubMed ID: 27725001
[TBL] [Abstract][Full Text] [Related]
9. Is Pulse Pressure an Independent Risk Factor for Incident Stroke, REasons for Geographic And Racial Differences in Stroke.
Glasser SP; Halberg DL; Sands CD; Mosher A; Muntner PM; Howard G
Am J Hypertens; 2015 Aug; 28(8):987-94. PubMed ID: 25588699
[TBL] [Abstract][Full Text] [Related]
10. Trends in Blood Pressure and Hypertension Among US Children and Adolescents, 1999-2018.
Hardy ST; Sakhuja S; Jaeger BC; Urbina EM; Suglia SF; Feig DI; Muntner P
JAMA Netw Open; 2021 Apr; 4(4):e213917. PubMed ID: 33792732
[TBL] [Abstract][Full Text] [Related]
11. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.
Dorjgochoo T; Gao YT; Chow WH; Shu XO; Yang G; Cai Q; Rothman N; Cai H; Li H; Deng X; Franke A; Roberts LJ; Milne G; Zheng W; Dai Q
Am J Clin Nutr; 2012 Aug; 96(2):405-14. PubMed ID: 22760572
[TBL] [Abstract][Full Text] [Related]
12. Increased F3-Isoprostanes in the Canadian Inuit Population Could Be Cardioprotective by Limiting F2-Isoprostane Production.
Alkazemi D; Jackson RL; Chan HM; Kubow S
J Clin Endocrinol Metab; 2016 Sep; 101(9):3264-71. PubMed ID: 27192695
[TBL] [Abstract][Full Text] [Related]
13. Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes.
Il'yasova D; Spasojevic I; Base K; Zhang H; Wang F; Young SP; Millington DS; D'Agostino RB; Wagenknecht LE
Diabetes Care; 2012 Jan; 35(1):173-4. PubMed ID: 22100959
[TBL] [Abstract][Full Text] [Related]
14. African Ancestry Gradient Is Associated with Lower Systemic F
Annor F; Goodman M; Thyagarajan B; Okosun I; Doumatey A; Gower BA; Il'yasova D
Oxid Med Cell Longev; 2017; 2017():8319176. PubMed ID: 28250893
[No Abstract] [Full Text] [Related]
15. Effects of 2 years of caloric restriction on oxidative status assessed by urinary F2-isoprostanes: The CALERIE 2 randomized clinical trial.
Il'yasova D; Fontana L; Bhapkar M; Pieper CF; Spasojevic I; Redman LM; Das SK; Huffman KM; Kraus WE;
Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29424490
[TBL] [Abstract][Full Text] [Related]
16. Associations of Anxiety Symptoms With 6-Year Blood Pressure Changes and Incident Hypertension: Results From the Hispanic Community Health Study/Study of Latinos.
Rosas CE; Pirzada A; Durazo-Arvizu R; Gallo LC; Talavera GA; Elfassy T; Cai J; Llabre MM; Perreira KM; Wassertheil-Smoller S; Daviglus ML; Sanchez-Johnsen LAP
Ann Behav Med; 2024 Jun; 58(7):488-497. PubMed ID: 38810223
[TBL] [Abstract][Full Text] [Related]
17. Association between lipid peroxidation and risk of type 2 diabetes in women.
Zhao Y; Milne GL; Chen Q; Dai Q; Zhang X; Nogueira MS; Cai H; Lan Q; Rothman N; Cai Q; Gao YT; Shu XO; Zheng W; Yang G
Free Radic Res; 2022; 56(7-8):536-543. PubMed ID: 36480242
[No Abstract] [Full Text] [Related]
18. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects.
Mori TA; Woodman RJ; Burke V; Puddey IB; Croft KD; Beilin LJ
Free Radic Biol Med; 2003 Oct; 35(7):772-81. PubMed ID: 14583341
[TBL] [Abstract][Full Text] [Related]
19. Antimüllerian hormone and F2-isoprostanes in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Kim C; Slaughter JC; Terry JG; Jacobs DR; Parikh N; Appiah D; Leader B; Moravek MB; Wellons MF
Fertil Steril; 2020 Sep; 114(3):646-652. PubMed ID: 32682516
[TBL] [Abstract][Full Text] [Related]
20. Association between F2-Isoprostane Metabolites and Weight Change in Older Women: A Longitudinal Analysis.
Zhao Y; Nogueira MS; Chen Q; Dai Q; Cai Q; Wen W; Lan Q; Rothman N; Gao YT; Shu XO; Zheng W; Milne GL; Yang G
Gerontology; 2024; 70(2):134-142. PubMed ID: 37967546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
